C30H29FIN5O10
Neat
765.49
Trametinib metabolite M4; Trametinib metabolite M9; 218N550XZ4; UNII-218N550XZ4; 1-(3-Amino-4-hydroxy-phenyl)-3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6, 8-dimethyl-pyrido(4, 3-d)pyrimidine-2, 4, 7-trione, glucuronide; 1620017-28-8; beta-D-Glucopyranosiduronic acid, 2-amino-4-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3, 4, 6, 7-tetrahydro-6, 8-dimethyl-2, 4, 7-trioxopyrido(4, 3-d)pyrimidin-1(2H)-yl)phenyl; Q27253535; .BETA.-D-GLUCOPYRANOSIDURONIC ACID, 2-AMINO-4-(3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-3, 4, 6, 7-TETRAHYDRO-6, 8-DIMETHYL-2, 4, 7-TRIOXOPYRIDO(4, 3-D)PYRIMIDIN-1(2H)-YL)PHENYL; glucuronide1-(3-amino-4-hydroxy-phenyl)-3-cyclopropyl-5-(2-fluoro-4-iodo-anilino)-6, 8-dimethyl-pyrido(4, 3-D)pyrimidine-2, 4 and 7-trione
(2S, 3S, 4S, 5R, 6S)-6-[2-amino-4-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6, 8-dimethyl-2, 4, 7-trioxopyrido[4, 3-d]pyrimidin-1-yl]phenoxy]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C30H29FIN5O10/c1-11-20-19(25(35(2)26(11)41)34-17-7-3-12(32)9-15(17)31)27(42)37(13-4-5-13)30(45)36(20)14-6-8-18(16(33)10-14)46-29-23(40)21(38)22(39)24(47-29)28(43)44/h3,6-10,13,21-24,29,34,38-40H,4-5,33H2,1-2H3,(H,43,44)/t21-,22-,23+,24-,29+/m0/s1